C3 and type 1 diabetes mellitus: Here, we present a novel cost-effective glycoproteomic workflow for a high-throughput and site-specific N-glycosylation LC-MS analysis of human C3 on a glycopeptide level, as well as evaluation of its potential for differentiating recent onset T1D in children.